Navigation Links
Kendle to Share Insights at Drug Information Association 45th Annual Meeting
Date:6/17/2009

CINCINNATI, June 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that several of its executives will present on important industry issues at the Drug Information Association (DIA) 45th Annual Meeting June 21-25, 2009, in San Diego, Calif. Kendle experts will address key topics in clinical development, including regulatory issues in portfolio management, pregnancy registries and risk management, and patient recruitment and retention for pregnancy registries.

Kendle Speakers

    Wednesday, June 24, 3:30-5 p.m., Room 14B
    Managing Development Portfolios in a Safety-Heightened Environment
    William K. Sietsema, PhD
    Vice President, U.S. Regulatory Consulting and Submissions

    Thursday, June 25, 8:30-10 a.m.
    Pregnancy Registries: Perspectives on a Unique Risk Management Tool
    Deborah Covington, DrPH, MS, Senior Director, Late Phase
    Laura F. McKain, MD, Medical Director, Registries and Epidemiology, Late
     Phase

    Poster Presentation
    Pregnancy Exposure Registries: Enhancing Recruitment and Retention
    Deborah Covington, DrPH, MS
    Senior Director, Late Phase

Kendle at Booth #439

Kendle experts will be available for on-site meetings and to discuss the Company's model for consistent quality execution of Phase I-IV clinical development programs and best practices in the development of strategic customer relationships.

In addition to Phase I-IV clinical development capabilities, the Kendle display also will highlight the Company's continued and recent success in delivering consistent quality and building effective site relationships as validated by independent third-party quantitative research. Kendle recently was named the highest-rated top-five CRO in the 2009 CenterWatch Survey of U.S. Investigative Sites. The Company is the only CRO to have been ranked consistently among the top two providers in the 2009, 2008 and 2007 CenterWatch surveys of U.S. and European investigative sites. In addition, according to the "2009 CRO Quality Benchmarking Report" published by Industry Standard Research (ISR), "Kendle delivers the most consistent quality services" as measured by the "Service Variability Index" (SVI), a measurement of consistency, which researchers at ISR identified as the most significant indicator of quality. Kendle's industry-best score was 12.2 (lower score = less variability, and closer to ideal distribution), while the industry average was 25.1. Kendle rated highest among CROs in the areas of CRA Quality, Consistent Quality Delivery, Meeting Project Timelines and Efficient Site Start-up.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO)


'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences
2. Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast
3. Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India
4. Kendle Revises Full Year 2008 Guidance
5. Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference
6. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
7. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
8. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
9. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
10. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
11. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology: